Combination drug suitable for treatment and prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration
AssigneeMedico Consl Co., Ltd
InventorsSatoru KUBOTA, Toru KONO
Life of this patent
Estimating the term…
Abstract
Problem to be Solved To provide medicine and health food suitable for treatment and prevention for non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH) which are not involved with hepatic virus, and/or hepatic fatty degeneration. Means for solving the problem A combination drug suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration, wherein the active ingredients are zinc preparation and selenium preparation.
Claims4
A combination drug suitable for treatment of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration, wherein the active ingredients are polaprezinc as zinc preparation and sodium selenite as selenium preparation.
(canceled)
Dependencies are inferred from the claim text.